STOCK GOODIES PLAYS OF THE WEEK

[MarketProphet]

Here is $ISOLF's News from Friday afternoon.

Isodiol International Inc. Signs Binding Agreement to Acquire 100% Stake in Be Tru Organics™
PRESS RELEASE GlobeNewswire
Dec. 1, 2017, 03:21 PM
VANCOUVER, B.C., Dec. 01, 2017 (GLOBE NEWSWIRE) -- Isodiol International Inc. (CSE:ISOL) (OTC:ISOLF) (FSE:LB6A.F) (the “Company” or “Isodiol”), a global Bioactive Phytoceutical innovator specializing in the development of pharmaceutical and wellness products, is pleased to announce that it has entered into a binding agreement to acquire 100% stake in Be Tru Organics™, a cause driven organization specializing in holistic products for everyday health and balance in the human body with the goal to promote well-being within the mind, body, & soul.

Be Tru is a formulator, marketer, and seller of a proprietary line of hemp extract products. Their offerings, which include topicals, oral sprays and edibles, contain powerful blends of more than 75 organic botanical terpenes and sold under the company’s Be Tru Organics™, Canatru™, and Cebatru™ brands.

“Isodiol and Be Tru share the common goal of providing consumers with high-quality products that promote physical and mental well-being,” said Marcos Agramont, CEO of Isodiol. “This strategic partnership would further enable us to diversify our product offerings, thus generating additional revenue streams. With both companies committed to being at the forefront of product innovation, this acquisition was an easy decision for us.”

Keith Gordon, CEO of Be Tru Organics, stated, “After our first discussion with Isodiol, it was a no-brainer that this partnership would not only be beneficial to both companies, but significantly strengthen our brands to benefit customers. We look forward to scaling our business and connecting with a group of global consumers that otherwise would have been inaccessible.”

As part of this agreement, Isodiol will issue Be Tru Organics™ up to $2,000,000 USD in stock, which will be payable at closing with shares of Isodiol’s common stock, valued at the closing price. This stock will be subject to a 36-month escrow as part of this agreement and anticipated to close within 30 days.

For more information on Isodiol, please visit www.isodiol.com

For more information on Be Tru Organics™, please visit www.betruorganics.com

About Isodiol International Inc.

Isodiol International Inc. is the market leader in pharmaceutical grade phytochemical compounds and the industry leader in the manufacturing and development of phytoceutical consumer products.

Isodiol is the pioneer of many firsts for the cannabis industry including commercialization of 99%+ pure, bioactive pharmaceutical grade cannabinoids, micro-encapsulations, and nanotechnology for the highest quality consumable and topical skin care products.

Isodiol's growth strategy includes the development of over-the-counter and pharmaceutical drugs, expanding its phytoceutical portfolio and will aggressively continue international expansion into Latin America, Asia and Europe.

Join Us On Facebook: https://www.facebook.com/isodiol/
Twitter:@isodiol

ON BEHALF OF THE BOARD
Marcos Agramont,CEO & Director
604-409-4409
[e-mail]

INVESTOR RELATIONS:
[e-mail]
www.isodiol.com

MEDIA CONTACT:
Carrie Booze
North 6th Agency
212-334-9753 ext.142
[e-mail]